BRONCHIOLITIS OBLITERANS SYNDROME (BOS)
Clinical trials for BRONCHIOLITIS OBLITERANS SYNDROME (BOS) explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS SYNDROME (BOS) trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS SYNDROME (BOS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood-filtering therapy may slow lung decline in transplant patients
Disease control OngoingThis phase 3 trial tests a treatment called extracorporeal photopheresis (ECP) for lung transplant patients who develop bronchiolitis obliterans syndrome (BOS), a form of chronic rejection. ECP involves filtering a patient's blood, treating it with a light-sensitive drug, and ret…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME (BOS)
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could faulty stem cells in the airways drive a rare lung disease? a study aims to find out.
Knowledge-focused TerminatedThis study explores whether stem cell dysfunction in the small airways causes bronchiolitis obliterans syndrome (BOS), a serious lung condition that can occur after a stem cell transplant. Researchers will collect airway cells from people with BOS and healthy volunteers to compar…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME (BOS)
Phase: NA • Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC